ROLANDO SANTOS: Open Payments
NPI 1366893927 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 66 payments from 13 companies in 2025. Trend: 2023 $1,289 · 2024 $1,211 · 2025 $1,278
Food & beverage: $1,278
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 17 | $431 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $234 |
| ABBVIE INC. | 16 | $174 |
| PFIZER INC. | 4 | $79 |
| SCILEX PHARMACEUTICALS INC. | 5 | $78 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $61 |
| Merz Pharmaceuticals, LLC | 3 | $51 |
| Forte Bio-Pharma LLC | 2 | $37 |
| Bioventus LLC | 1 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
Products named: IBSRELA, RELISTOR, QULIPTA, ZTLido, JOURNAVX, NURTEC ODT, Xeomin, PROLATE.
Industry payments across CA — which companies pay providers there.
